BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical implantation of OsteoSelect PLUS Demineralized Bone Matrix (DBM) Putty,

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone